Regeneron Pharma (REGN) PT Lowered to $392 at RBC Capital
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $788.04 -1%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $392.00 (from $397.00) while maintaining a Sector Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Natera (NTRA) PT Raised to $460 at RBC Capital on 'Strong Setup'
- Zscaler (ZS) PT Raised to $236 at RBC Capital
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR4,665 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
